InsiderTrades.com logo
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
From Colonial Metals   |   Ad
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…
Claim your FREE 2024 Gold Guide
Amato Giaccia net worth and biography
  • Phone
  • Email
  • Website

Amato Giaccia Biography and Net Worth

Director of Aravive
Dr. Giaccia has served as a member of the Board of Directors since October 2018.  Prior to the closing date of the Merger, he also served as a member of the board of directors of Aravive Biologics from August 2010 to October 2018 and as Acting Chief Scientific Officer of Private Aravive from January 2017 until the Merger was completed on October 12, 2018. Dr. Giaccia also served as Professor of Radiation Oncology, Associate Chair for Research & Director of the Division of Radiation & Cancer Biology in the Department of Radiation Oncology at Stanford University School of Medicine, a position he has held since 2011 and has been a Director of Oxford Institute of Radiation Oncology since January 2019.  He is also the Associate Director for Basic Science and leader of the Radiation Biology Program in Stanford Cancer Institute. He has also served as the Director of the Cancer Biology Interdisciplinary Graduate Program and is currently the “Jack, Lulu and Sam Willson Professor in Cancer Biology” in the Stanford University School of Medicine. He received his Ph.D. from the University of Pennsylvania.

How do I contact Amato Giaccia?

The corporate mailing address for Dr. Giaccia and other Aravive executives is River Oaks Tower 3730 Kirby Drive Suite 1200, Houston TX, 77098. Aravive can also be reached via phone at (936) 355-1910 and via email at [email protected]. Learn More on Amato Giaccia's contact information.

Has Amato Giaccia been buying or selling shares of Aravive?

Amato Giaccia has not been actively trading shares of Aravive during the past quarter. Most recently, Amato Giaccia sold 3,245 shares of the business's stock in a transaction on Tuesday, November 30th. The shares were sold at an average price of $3.22, for a transaction totalling $10,448.90. Learn More on Amato Giaccia's trading history.

Who are Aravive's active insiders?

Aravive's insider roster includes Amato Giaccia (Director), and Gail Mcintyre (CEO). Learn More on Aravive's active insiders.

Amato Giaccia Insider Trading History at Aravive

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/30/2021Sell3,245$3.22$10,448.90View SEC Filing Icon  
See Full Table

Amato Giaccia Buying and Selling Activity at Aravive

This chart shows Amato Giaccia's buying and selling at Aravive by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aravive Company Overview

Aravive logo
Aravive, Inc., a clinical-stage biopharmaceutical company, develops transformative treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a license and collaboration agreement with WuXi Biologics (Hong Kong) Limited to identify and develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain batiraxcept as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas.
Read More

Today's Range

Now: $0.04
Low: $0.04
High: $0.04

50 Day Range

MA: $0.04
Low: $0.04
High: $0.04

2 Week Range

Now: $0.04
Low: $0.04
High: $2.46

Volume

N/A

Average Volume

N/A

Market Capitalization

$2.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
From Colonial Metals   |   Ad
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…
Claim your FREE 2024 Gold Guide